Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Ellipta“
Suchtreffer
Begriffe & Kennungen
Laventair Ellipta (previously Laventair) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · 5 umeclidinium or vilanterol Cmax. An approximately 1.4-fold increase in umeclidinium AUC was observed with no
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Although no formal in vivo drug interaction studies have been performed, inhaled umeclidinium/vilanterol has b
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Beta-adrenergic blockers
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Beta2-adrenergic blockers may weaken or antagonise the effect of beta2-adrenergic agonists, such as vilanterol
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Both umeclidinium and vilanterol are substrates of the P-glycoprotein transporter (P-gp). The effect of the mo
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Clinically significant interactions mediated by umeclidinium/vilanterol at clinical doses are considered unlik
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Co-administration of umeclidinium/vilanterol with other long-acting muscarinic antagonists, long-acting beta2-
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Concomitant hypokalaemic treatment with methylxanthine derivatives, steroids, or non-potassium-sparing diureti
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Hypokalaemia
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Metabolic and transporter based interactions
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Other antimuscarinics and sympathomimetics
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Other medicinal products for COPD
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Umeclidinium is a substrate of cytochrome P450 2D6 (CYP2D6). The steady-state pharmacokinetics of umeclidinium
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.5 · Vilanterol is a substrate of cytochrome P450 3A4 (CYP3A4). Concomitant administration of strong CYP3A4 inhibit
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 Undesirable effects · 1
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · 7 System Organ Class Adverse reactions Frequency
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · Infections and infestations Urinary tract infection Common Sinusitis Common Nasopharyngitis Common Pharyngitis
Eintrag öffnen